Corticosteroids with Anti-infectives (eye)
Drug Safety Update
May 2024: Topical steroids: introduction of new labelling and a reminder of the possibility of severe side effects, including Topical Steroid Withdrawal Reactions
August 2017: Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration.
Use of combination products is rarely justified except after ocular surgery to reduce inflammation and prevent infections.
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary